参考文献/References:
[1] 陈颖, 王伟佳, 胡婷, 等. 急性胰腺炎患者血清C1q补体水平与疾病严重程度的相关性研究[J]. 现代检验医学杂志, 2021, 36(4): 45-50. CHEN Ying, WANG Weijia, HU Ting, et al. Research on relevant serum C1q complement level in the severity of acute pancreatitis[J]. Journal of Modern Laboratory Medicine, 2021, 36(4): 45-50.
[2] 杨威, 黄咏宁, 吕元博, 等. 重症急性胰腺炎患者外周血TLR4,TRAF6 的表达及与并发肝损伤的关系[J]. 中国现代医学杂志, 2023, 33(12): 18-23. YANG Wei, HUANG Yongning, L? Yuanbo, et al. Expressions of TLR4 and TRAF6 in the peripheral blood of patients with severe acute pancreatitis and their associations with liver injury[J]. China Journal of Modern Medicine, 2023, 33(12): 18-23.
[3] 吴冲, 邢益门, 周婷, 等. 老年急性胰腺炎患者血清miR-29a 表达水平及其对并发急性肾损伤的预测价值[J]. 中国老年学杂志, 2023, 43(18): 4392-4394. WU Chong, XING Yimen, ZHOU Ting, et al. Serum miR-29a expression level in elderly patients with acute pancreatitis and its predictive value for concurrent acute kidney injury[J]. Chinese Journal of Gerontology, 2023, 43(18): 4392-4394.
[4] 刘兴涛, 王天舒, 覃海森, 等. 急性胰腺炎患者外周血miRNA-16 和miRNA-192 表达及其与病情严重程度的相关性[J]. 岭南急诊医学杂志, 2021, 26(4):348-351. LIU Xingtao, WANG Tianshu, QIN Haisen, et al. Expression of miRNA-16 and miRNA-192 in peripheral blood of patients with acute pancreatitis and its correlation with disease severity[J]. Lingnan Journal of Emergency Medicine, 2021, 26(4): 348-351.
[5] HAO Shunxin, YAO Zhi, LIU Yifeng. Hsa_ circ_0000106 acts as a tumor promoter in pancreatic cancer by targeting the miR-455-3p/HDAC4[J]. Hormone and Metabolic Research, 2023, 55(10): 722- 732.
[6] HU Qiongyi, GONG Wen, GU Jieyu, et al. Plasma microRNA profiles as a potential biomarker in differentiating adult-onset still’s disease from sepsis[J]. Frontiers in Immunology, 2018, 9: 3099.
[7] 中国医师协会胰腺病学专业委员会. 中国急性胰腺炎多学科诊治共识意见[J]. 临床肝胆病杂志, 2015,31(11): 1770-1775. Pancreatology Committee of Chinese Medical Doctor Association. Chinese consensus on the multidisciplinary treatment (MDT) of acute pancreatitis[J]. Journal of Clinical Hepatology, 2015, 31(11): 1770-1775.
[8] 中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华消化外科杂志, 2021,20(7): 730-739. Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China (2021)[J]. Chinese Journal of Digestive Surgery, 2021, 20(7): 730-739.
[9] 李佳敏, 房智超, 王树楷, 等. 线粒体功能障碍及线粒体自噬异常在急性胰腺炎中的作用[J]. 中国现代医学杂志, 2023, 33(12): 58-64. LI Jiamin, FANG Zhichao, WANG Shukai, et al. The role of mitochondrial dysfunction and abnormal mitophagy in acute pancreatitis[J]. China Journal of Modern Medicine, 2023, 33(12): 58-64.
[10] 邓雍, 马涛, 张宁. 重症急性胰腺炎病人外周血微RNA-143-3p, 环氧合酶-2 表达水平与辅助性T细胞17/ 调节性T 细胞平衡的关系[J]. 安徽医药,2023, 27(11): 2198-2202. DENG Yong, MA Tao, ZHANG Ning. The relationship between the expression levels of miR-143-3p, COX-2 and Th17/Treg balance in peripheral blood of patients with severe acute pancreatitis[J]. Anhui Medical and Pharmaceutical Journal, 2023, 27(11): 2198-2202.
[11] 杨卿青, 秦继武, 张超, 等. 血清抗凝血酶- Ⅲ联合改良CT 严重指数评估急性胰腺炎患者病情严重程度及预后的临床价值[J]. 临床和实验医学杂志,2023, 22(17): 1797-1800. YANG Qingqing, QIN Jiwu, ZHANG Chao, et al. Value of serum antithrombin- Ⅲ combined with modified CT severity index in evaluating the severity and prognosis of acute pancreatitis patients[J]. Journal of Clinical and Experimental Medicine, 2023, 22(17): 1797-1800.
[12] YANG Yi, HUANG Qilin, LUO Chen, et al. MicroRNAs in acute pancreatitis: from pathogenesis to novel diagnosis and therapy[J]. Journal of Cellular Physiology, 2020, 235(3): 1948-1961.
[13] 陈映群, 张卫星, 尹子涵, 等. 微小RNA-375 在急性胰腺炎患者外周血中的表达及与并发急性肝损伤的相关性[J]. 分子诊断与治疗杂志, 2022, 14(12):2150-2153, 2158. CHEN Yingqun, ZHANG Weixing, YIN Zihan, et al. Expression of microRNA-375 in peripheral blood of patients with acute pancreatitis and its correlation with concurrent acute liver injury[J]. Journal of Molecular Diagnosis and Therapy, 2022, 14(12): 2150-2153, 2158.
[14] VASU S, SARACINO G, DARDEN C M, et al. Clinical and biological significance of circulating miRNAs in chronic pancreatitis patients undergoing total pancreatectomy with islet autotransplantation[J]. Clinical and Translational Medicine, 2023, 13(10): e1434.
[15] ZHOU Wence, DONG Shi, CHEN Zhou, et al. New challenges for microRNAs in acute pancreatitis: progress and treatment[J]. Journal of Translational Medicine, 2022, 20(1): 192.
[16] KURASHIGE S, MATSUTANI N, AOKI T, et al. Evaluation of circulating miR-216a and miR-217 as biomarkers of pancreatic damage in the L-arginineinduced acute pancreatitis mouse model[J]. Journal of Toxicological Sciences, 2023, 48(10): 527-534.
[17] ZHAN Ting, ZHU Qingxi, HAN Zheng, et al. MiR- 455-3p functions as a tumor suppressor by restraining Wnt/β-catenin signaling via TAZ in pancreatic cancer[J]. Cancer Management and Research, 2020, 12: 1483-1492.
[18] ZHAN Yinchu, CHEN Chenlin, WU Zhiqiang, et al. MiR-455-3p ameliorates pancreatic acinar cell injury by targeting SLC2A1[J]. Peer J, 2023, 11: e15612.
[19] YU Yali, DONG Guixiang, LI Zijun, et al. Circ-LRP6 contributes to osteosarcoma progression by regulating the miR-141-3p/HDAC4/HMGB1 axis[J]. International Journal of Oncology, 2022, 60(4): 38.
[20] SONG Guodong, ZHOU Jia, SONG Ruimei, et al. Long noncoding RNA H19 regulates the therapeutic efficacy of mesenchymal stem cells in rats with severe acute pancreatitis by sponging miR-138-5p and miR-141-3p[J]. Stem Cell Research & Therapy, 2020, 11(1): 420.